Concept information
Preferred term
17 alpha-Hydroxyprogesterone Caproate
Type
-
mesh:Descriptor
Definition
- Hydroxyprogesterone derivative that acts as a PROGESTIN and is used to reduce the risk of recurrent MISCARRIAGE and of PREMATURE BIRTH. It is also used in combination with ESTROGEN in the management of MENSTRUATION DISORDERS.
Broader concept
Entry terms
- 17-alpha-Hydroxy-Progesterone Caproate
- 17 alpha-Oxyprogesterone Capronate
- 17-Hydroxyprogesterone Capronate
- 276F2O42F5
- 630-56-8
- Hexanoic acid, 3,20-dioxopregn-4-en-17-yl ester
- Hydroxyprogesterone Caproate
- Hydroxyprogesterone Hexanoate
- Oxyprogesterone Caproate
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
276F2O42F5
-
630-56-8
-
Hexanoic acid, 3,20-dioxopregn-4-en-17-yl ester
URI
http://data.loterre.fr/ark:/67375/JVR-VHWNPXF1-M
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}